India-based diagnostics technology developer Tricog Health has raised $10.5m in a series B round featuring Aflac Ventures, part of insurance provider Aflac’s collaborative innovation arm, Aflac Innovation Partners, the Economic Times reported yesterday.
University of Tokyo’s venture capital unit, University of Tokyo Edge Capital (Utec), also participated, as did Inventus Capital, Blume Ventures, TeamFund and Dream Incubator.
Tricog has built a technology platform that applies artificial intelligence to assist in the diagnosis of cardiac disease. Its Insta ECG system combines electrocardiogram monitoring with cloud-based analytics, and is already deployed in more than 2,500 hospitals, clinics and diagnostics labs.
The company will will invest the funding in its product and growth strategy, building out across Asian and African countries including China, Malaysia and Singapore as well as in Japan, where it has been collaborating with Utec.
Utec joined unnamed investors to provide $4m in funding for Tricog in February 2018, following a series A round of undisclosed size in 2016 backed by Inventus Capital Partners, Blume Ventures and multiple angel investors. Tricog has now raised $17.5m in all, according to ET.
The original version of this article appeared on our sister site, Global University Venturing.